Publication - First Ascent Biomedical

ASCO 2024 Clinical Results

Our study shows the technical feasibility of integrating functional precision [...]

Our studies demonstrate the potential for predictive and generative artificial [...]

John Verducci2024-04-29T15:42:56+00:00April 29, 2024|Publication|

First Ascent Biomedical Inc., a clinical-stage functional precision medicine company [...]

John Verducci2024-04-18T23:42:36+00:00April 18, 2024|Publication|

Inside Precision Medicine April 18, 2024 IPM interviewed Dr. Diana [...]

John Verducci2023-06-15T18:31:47+00:00June 15, 2023|Publication|

Risk or presence of metastasis in medulloblastoma causes substantial treatment-related [...]

John Verducci2023-06-15T19:02:20+00:00March 23, 2023|Publication|

Systemic therapy for metastatic clear cell sarcoma (CCS) bearing EWSR1-CREB1/ATF1 [...]

John Verducci2023-06-15T18:24:42+00:00September 17, 2022|Publication|

Over the past 25 years, chemotherapy regimens for osteosarcoma have [...]

John Verducci2023-06-15T18:29:58+00:00July 1, 2022|Publication|

Metastatic epithelioid sarcoma (EPS) remains a largely unmet clinical need [...]

John Verducci2023-05-18T14:20:47+00:00May 30, 2022|Publication|

Moving drugs to and through phased trials, especially in cancer, [...]

John Verducci2023-06-15T18:16:49+00:00April 21, 2022|Publication|

orrectly diagnosing a rare childhood cancer such as sarcoma can [...]